Biblio
Export 66 results:
[ Author
Filters: First Letter Of Last Name is J [Clear All Filters]
“The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease.”, J Alzheimers Dis, vol. 78, no. 2, pp. 573-585, 2020.
, “B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 84, no. 3, pp. 1039-1055, 2021.
, “Expression of the Alzheimer's Disease Mutations AβPP695sw and PSEN1M146I in Double-Transgenic Göttingen Minipigs.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1617-30, 2016.
, “Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 145-59, 2016.
, “Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.”, J Alzheimers Dis, vol. 49, no. 3, pp. 671-80, 2016.
, “Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1603-1609, 2022.
, “It's Groundhog Day! What Can the History of Science Say About the Crisis in Alzheimer's Disease Research?”, J Alzheimers Dis, vol. 90, no. 4, pp. 1401-1415, 2022.
, “Persistence with Antihypertensive Drugs in Patients with Hypertension and Dementia in Germany.”, J Alzheimers Dis, vol. 60, no. 2, pp. 505-510, 2017.
, “Risk Factors for Mild Cognitive Impairment in German Primary Care Practices.”, J Alzheimers Dis, vol. 56, no. 1, pp. 379-384, 2017.
, “Prevalence of Use of Cardiovascular Drugs in Dementia Patients Treated in General Practices in Germany.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1519-1524, 2017.
, “How Different are Quality of Life Ratings for People with Dementia Reported by Their Family Caregivers from Those Reported by the Patients Themselves?”, J Alzheimers Dis, vol. 55, no. 1, pp. 259-267, 2017.
, “Evidence for ordering of Alzheimer disease biomarkers.”, Arch Neurol, vol. 68, no. 12, pp. 1526-35, 2011.
, “Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.”, Lancet Neurol, vol. 12, no. 2, pp. 207-16, 2013.
, “An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”, Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
, “Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.”, J Alzheimers Dis, vol. 74, no. 1, pp. 277-286, 2020.
, “Identification of Physician-Diagnosed Alzheimer's Disease and Related Dementias in Population-Based Administrative Data: A Validation Study Using Family Physicians' Electronic Medical Records.”, J Alzheimers Dis, vol. 54, no. 1, pp. 337-49, 2016.
,